Intramuscular self-injection is more difficult and typically requires training or assistance
PMCID: PMC4309183
It is indicated for the treatment of Polyneuropathy of any origin such as Diabetic, Alcoholic or Toxic neuropathies, Neuritis, Neuralgia, Cervical Syndrome, Shoulder-arm syndrome, Lumbago, Sciatica, Mayalgia, Herpes Zoster, Trigeminal Neuralgia, Supportive treatment in facial paresis Dosage & Administration: Tablet: 1 to 3 tablets daily or as directed by the physician
International Journal of Peptide Science , 14(3), 117126
Advanced injectable protocol Goal: Maximum efficacy, willing to inject, committed to comprehensive protocol
These are typically administered either intramuscularly (IM) or intravenously (IV), depending on the product and the individuals needs